Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co

Ex-Purdue CEO stands to earn a huge windfall in Novartis' buyout of the Medicines Co

Source: 
Endpoints
snippet: 

Mark Timney, the ex-Purdue Pharma CEO named in dozens of lawsuits against the OxyContin maker, stands to earn over $85 million in Novartis’s $9.7 billion buyout of the Medicines Company.